A randomized crossover clinical trial of multi‐periscopic and Fresnel peripheral prism glasses for hemianopia
Optometry and Vision Science · 2026-06 · 103 (6)
DOI: 10.1002/ovs2.70072 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Optometry and Vision Science, online erschienen am 11.06.2026. Verfasst von Alex R Bowers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Schepens Eye Research Institute of Mass Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Eyeglasses, Hemianopsia, Visual Fields, Visual Acuity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, National Eye Institute.
Abstract (Originalsprache)
Purpose
To compare novel multi‐periscopic prisms (MPP; 42° field expansion) to commercial Fresnel peripheral prisms (FPP; 30° field expansion) as mobility devices to assist with pedestrian collision hazard detection when walking.
Methods
Participants with hemianopia without neglect or cognitive decline were recruited at 7 sites in a single‐masked crossover trial, allocated by minimization to receive either MPP or FPP first. Pedestrian collision detection was evaluated after 4‐weeks of home‐use of each type of prisms. The test simulated walking through a busy shopping mall with multiple pedestrians; in each trial, one pedestrian could be on a collision course, bearing angle of ±20° or ±40°, or there could be no colliding pedestrian. The main outcome, improvement with prisms (yes/no), was defined as blind‐side detection rates that were significantly higher with than without prisms at the same visit.
Results
Of 64 participants screened, 38 were eligible and 63% (24/38) showed improvement with at least one type of prism glasses. There were no differences between the proportions of participants showing improvement with MPPs and FPPs for either 40° blind‐side pedestrians (MPPs 31%, 12/38 vs. FPPs 26%, 10/38; difference 5%; 95% CI −14% to 24%, p = 0.75) or 20° blind‐side pedestrians (MPPs 37%, 14/38 vs. FPPs 42%, 16/38; difference −5%; 95% CI −24% to 14%, p = 0.75). Of the 32 participants who completed both crossover periods, 13 (41%) preferred MPPs whereas 19 (59%) preferred FPPs ( p = 0.38). MPPs were preferred for image clarity and extent of field expansion and FPPs for cosmetic appearance. Both MPPs and FPPs reduced ( p < 0.01) perceived difficulty when walking in unfamiliar areas, crowded situations, detecting objects and people on the blind side, the most difficult situations without prisms.
Conclusions
Both MPPs and FPPs improved blind‐side collision detection at large (40°) as well as smaller (20°) bearing angles. These positive results strengthen the evidence base for FPPs and establish the potential of MPPs as mobility devices for patients with hemianopia. Trial Registration ClinicalTrials.gov NCT 04827147, registered on 04/01/2021.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Schepens Eye Research Institute of Mass Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.
- CooperVision, Southampton, UK.
Förderung
- NEI NIH HHS
- National Eye Institute
Zitieren
APA
Bowers, A. R., Manda, S., Shekar, S., Hwang, A. D., Jung, J. H., & Peli, E. (2026). A randomized crossover clinical trial of multi‐periscopic and Fresnel peripheral prism glasses for hemianopia. Optometry and Vision Science, 103(6). https://doi.org/10.1002/ovs2.70072
Vancouver
Bowers AR, Manda S, Shekar S, Hwang AD, Jung JH, Peli E. A randomized crossover clinical trial of multi‐periscopic and Fresnel peripheral prism glasses for hemianopia. Optometry and Vision Science. 2026;103(6). doi:10.1002/ovs2.70072
BibTeX
@article{Bowers2026,
author = {Bowers, Alex R and Manda, Sailaja and Shekar, Sandhya and Hwang, Alex Daejoon and Jung, Jae-Hyun and Peli, Eli},
title = {A randomized crossover clinical trial of multi‐periscopic and Fresnel peripheral prism glasses for hemianopia},
journal = {Optometry and Vision Science},
year = {2026},
volume = {103},
number = {6},
doi = {10.1002/ovs2.70072}
}
EUVIMED